Didier Dewailly
Reproductive Medicine · 2003–2018
A researcher in the Science corpus: 8 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Reproductive Medicine — 62 citations into it
- Public Health, Environmental and Occupational Health — 35 citations into it
- Cardiology and Cardiovascular Medicine — 17 citations into it
Whom Didier Dewailly trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Didier Dewailly overall
Papers from Didier Dewailly's perspective
Ordered by how strongly the researchers Didier Dewailly trusts endorse each paper. Same corpus, a different order for every researcher.
- Polycystic ovary syndrome (Nature Reviews Disease Primers)
- Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial. (Journal of Clinical Endocrinology and Metabolism)
- AGREE II: advancing guideline development, reporting and evaluation in health care (Canadian Medical Association Journal)
- The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. (European Journal of Endocrinology)
- Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. (Journal of the American Medical Association (JAMA))
- Ultrasound assessment of the polycystic ovary: international consensus definitions. (Human Reproduction Update)
- Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. (Journal of Clinical Endocrinology and Metabolism)
- Diagnosis and complications of Cushing's syndrome: a consensus statement. (Journal of Clinical Endocrinology and Metabolism)
- The metabolic syndrome: time for a critical appraisal (Diabetologia)
- The molecular classification of the clinical manifestations of Crohn's disease. (Gastroenterology)
Their papers
- Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome (2018) — 2,461 citations
- The physiology and clinical utility of anti-Mullerian hormone in women. (2014) — 954 citations
- The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. (2014) — 604 citations
- The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. (2009) — 2,022 citations
- Polycystic ovary syndrome (2007) — 649 citations
- Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. (2006) — 1,909 citations
- Ultrasound assessment of the polycystic ovary: international consensus definitions. (2003) — 1,033 citations
- Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. (2003) — 708 citations